ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health and reversing chronic illness, today announced it will host a free webinar on October 24, 2012 at 4 p.m. PT focused on the applications of medical foods for nutritionally supporting the dietary management of chronic illnesses. The Metagenics University webinar, “Medical Foods: Nutritional Solutions to Chronic Disease” will be presented by Jacob Kornberg MD, FACS, director of medical education at the Metagenics Functional Medicine Research Center® (FMRC).
“Dietary management is a critical element in patient care that is often overlooked during the early stages of disease onset and in ongoing clinical management of chronic illness as well,” said Dr. Kornberg. “Medical foods, a special category of food with unique requirements outlined by the FDA, can be an important part of the nutritional management of for medical conditions with distinctive nutritional requirements. Medical foods are an especially important option to incorporate into clinical care as patients look to their physicians for a more comprehensive approach to disease management that avoids the side effects and safety concerns of many existing pharmaceutical drugs.”
The webinar will focus on findings from Metagenics’ research team of physicians and scientists, such as:
- The potential role of Metagenics' selective kinase response modulator (SKRM) technology in positively influencing cellular function and helping to manage inflammation that is linked to many diseases. These proprietary, naturally derived SKRM ingredients were found in laboratory testing at the MetaProteomics® Research Center (the laboratory research arm of Metagenics, Inc.) to target and positively influence cellular signaling that has been disrupted by kinase activity associated with compromised functioning and disease.
- Published research showing the effectiveness of medical foods, such as an article published last year in the Journal of Clinical Lipidology on the results of a clinical trial at three universities. This 12-week study demonstrated that Metagenics’ UltraMeal® Plus 360˚ medical food in combination with a low-glycemic-load, Mediterranean-style diet was 40% more effective than the diet alone in resolving metabolic syndrome, a condition that increases the risk for cardiovascular disease (CVD) and type 2 diabetes and affects one-third of all American adults.
- Clinical applications for other medical foods, including the dietary management of CVD conditions, type 2 diabetes, gastrointestinal disorders and illnesses characterized by fatigue and pain.
Click here to register for the “Medical Foods: Nutritional Solutions to Chronic Disease” webinar that will take place on October 24, 2012 at 4 p.m. PT.
About Metagenics, Inc.
Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company dedicated to helping people live happier, healthier lives by realizing their genetic potential. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs such as FirstLine Therapy to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.
Metagenics maintains its corporate headquarters in Aliso Viejo, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium and Brisbane, Australia.
Scott Public Relations
Joy Scott, 818-610-0270
Source: Metagenics, Inc.